Future hepatitis cure rates expected to soar
After “astonishing” preliminary results from new drugs As the burden of Hepatitis C (HCV) associated liver failure and liver cancer rises in our community so hepatitis C therapy is undergoing radical and rapid change, says Centenary’s Prof Geoff McCaughan.
